Scinovex
article

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

European Journal of Cancer · 1998 · Vol. 34(4) · pp. 503–509
Jervoise AndreyevA. NormanJ. OatesDavid Cunningham
Nutrition and Health in AgingGastric Cancer Management and OutcomesCancer Diagnosis and TreatmentWeight lossMedicineChemotherapyHazard ratioInternal medicineGastroenterologyRetrospective cohort studyRectumSurgeryObesity

MeSH terms

AdenocarcinomaAdolescentAdultAgedAged, 80 and overAntimetabolites, AntineoplasticCarcinoma, Squamous CellEsophageal NeoplasmsFemaleFluorouracilGastrointestinal NeoplasmsHumansMaleMiddle AgedPancreatic Neoplasms
Citations
804
FWCI
2.47
field-weighted impact
References
28
Percentile
89%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? · Scinovex